Sign in

You're signed outSign in or to get full access.

Stephen Gulis Jr.

Chair of the Board at INDEPENDENT BANK CORP /MI/
Board

About Stephen L. Gulis, Jr.

Stephen L. Gulis, Jr. (age 67) is Independent Bank Corporation’s non-executive Chairperson of the Board, serving on the board since 2004; he is designated independent under NASDAQ rules. He is a former Executive Vice President, CFO and Treasurer of Wolverine Worldwide and retired in 2008 as President of Wolverine Worldwide Global Operations; earlier he was a certified public accountant with Touche Ross & Company. He also serves as a director of Sleep Number Corporation (Nasdaq: SNBR), bringing deep financial and operations experience to IBCP’s board leadership.

Past Roles

OrganizationRoleTenureCommittees/Impact
Wolverine WorldwidePresident, Global Operations GroupUntil 2008Led global operations; prior EVP, CFO & Treasurer brings financial discipline to board deliberations
Wolverine WorldwideExecutive Vice President, CFO & TreasurerPre-2008Public company CFO experience supports audit, risk, and compensation oversight
Touche Ross & CompanyCertified Public AccountantPrior to Wolverine WorldwideCPA background enhances audit-quality, financial reporting and control oversight

External Roles

OrganizationRoleTenureCommittees/Impact
Sleep Number Corporation (Nasdaq: SNBR)DirectorCurrentPublic company board service adds consumer/retail operating and governance perspective
Several privately held organizationsIndependent financial/operations/management advisorCurrentAdvisory engagements broaden operational benchmarking and governance insights

Board Governance

  • Role: Non-executive Chairperson of the Board (effective April 23, 2024)
  • Independence: Board determined Gulis is “Independent Director” under NASDAQ Listing Rule 5605(a)(2)
  • Committee assignments: Compensation Committee member; signed Compensation Committee Report (with Budden and Keller)
  • Chair roles history: Audit Committee Chair through April 23, 2024; became Board Chair thereafter (fees reflect prorated chair retainer)
  • Attendance: Board held seven meetings in 2024; each director attended at least 75% of board and applicable committee meetings; all directors attended 2024 annual meeting
  • Leadership structure: CEO and Chair roles are separated (Kessel is CEO; Gulis is Chair); Lead Independent Director role assigned to Boer for sessions without Chair/CEO; board regularly holds executive sessions without management
  • Majority voting: Bylaws amended in 2017 to adopt majority voting for directors

Fixed Compensation

Component (2024)AmountNotes
Fees Earned or Paid in Cash$94,950Includes base director retainer and prorated chair fees (audit chair to 4/23/24; board chair from 4/23/24)
Fees Earned or Paid in Stock$0No stock portion elected in 2024
Total Director Compensation$94,950No meeting fees beyond retainers
  • Retainer structure (reference amounts): Annual non-employee director retainer $68,000; Chair of Board $36,500; Audit Chair $10,400; Compensation Chair $6,250; Nominating & Corporate Governance Chair $6,250. Half of combined retainer paid in cash and half in stock until ownership guideline met; thereafter director may elect cash or stock via Purchase Plan. Stock ownership guideline: at least $300,000 market value within five years of joining the board.

Performance Compensation

  • Directors do not receive performance-based awards; however, as Compensation Committee member, Gulis oversees executive incentive metrics. Key 2024 plan metrics and outcomes:
MetricThreshold (50%)Target (100%)Maximum (200%)2024 PerformancePerformance FactorWeightPayout Ratio
Earnings Per Share$2.74 $2.99 $3.49 $3.16 1.34 40% 0.54
Efficiency Ratio60.00% 59.00% 56.00% 60.83% 12% 0.00
Non-Performing Assets / Total Assets0.50% 0.30% 0.10% 0.13% 1.85 12% 0.22
Deposit Balance Growth (ex-brokered)2.50% 5.00% 10.00% 6.33% 1.27 16% 0.20
  • 2025 metrics: EPS threshold $2.80; target $3.15; maximum $3.56; same weights; bonuses not payable unless EPS ≥ $2.67; efficiency ratio 60/59/56; NPA/Assets 0.50/0.30/0.10; deposit growth 2.5/5.0/10.0 .

Other Directorships & Interlocks

CompanyRoleCommittee Interlocks/Conflicts Disclosed
Sleep Number Corporation (Nasdaq: SNBR)DirectorNo IBCP compensation committee interlocks requiring disclosure in 2024
  • Compensation Committee Interlocks: “No relationships requiring disclosure under Item 407(e)(4) of Regulation S-K” for 2024.

Expertise & Qualifications

  • Public company governance: Non-executive Chair at IBCP; director at Sleep Number Corporation
  • Financial expertise: Former public company CFO; CPA background (Touche Ross)
  • Operational leadership: Led global operations at Wolverine Worldwide; advisor to private companies on finance/operations/management
  • Independence: Determined independent by the board under NASDAQ rules

Equity Ownership

Ownership CategoryShares% OutstandingNotes
Beneficial Ownership (direct/indirect)—%Not disclosed for direct beneficial ownership in table
Deferred Shares (to be issued from trust)61,5710.29%Deferred under director Purchase Plan; not currently voted/sold; trust held total 168,049 shares for directors
Shares PledgedProhibitedInsider trading policy prohibits pledging and hedging for directors
Stock Ownership Guideline$300,000 required within 5 yearsHalf retainer in stock until guideline met; thereafter cash/stock election permitted

Insider Trades

ItemStatus
Section 16(a) compliance for directorsAll timely in 2024; no issues noted for Gulis
Form 4 transactions disclosed (proxy)Not disclosed in proxy materials

Governance Assessment

  • Positive signals:
    • Non-executive Chair with independent status; CEO/Chair separation supports oversight and risk governance. Executive sessions occur regularly without management; Lead Independent Director identified for sessions without Chair/CEO.
    • Active Compensation Committee member who signed the committee report; oversight includes use of Meridian Compensation Partners for peer benchmarking; say-on-pay support was strong at 96.1% in 2024.
    • Ownership alignment via director stock ownership guideline ($300,000) and deferred stock plan; pledging/hedging prohibited for directors.
  • Potential concerns/monitoring items:
    • Role transition from Audit Chair to Board Chair in 2024 centralizes influence; continued focus on committee independence and board refreshment helps mitigate.
    • Related-party banking transactions exist in ordinary course (aggregate loans to directors/executives $3.938 million, 0.9% of equity) but disclosed as market terms; no unfavorable features reported.
    • Attendance disclosed at “≥75%” rather than precise rates; maintain monitoring of engagement levels; all directors attended 2024 annual meeting.

Shareholder feedback: Advisory say-on-pay approval was ~96.1% in 2024; board made no material changes to executive pay policies as a result, indicating investor support for compensation governance.